Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor

Cannabidiol (CBD), the major non-psychotomimetic compound present in the Cannabis sativa plant, exhibits therapeutic potential for various human diseases, including chronic neurodegenerative diseases, such as Alz...

Source: Molecular Brain - September 17, 2018 Category: Neuroscience Authors: Mar ía Rodríguez-Muñoz, Yara Onetti, Elsa Cortés-Montero, Javier Garzón and Pilar Sánchez-Blázquez Tags: Research Source Type: research